- Home
- CNTX vs UPLD Comparison
CNTX vs UPLD Comparison
Compare CNTX & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- UPLD
- Stock Information
- Founded
- CNTX 2015
- UPLD 2010
- Country
- CNTX United States
- UPLD United States
- Employees
- CNTX N/A
- UPLD N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- UPLD Computer Software: Prepackaged Software
- Sector
- CNTX Health Care
- UPLD Technology
- Exchange
- CNTX Nasdaq
- UPLD Nasdaq
- Market Cap
- CNTX 75.6M
- UPLD 71.9M
- IPO Year
- CNTX 2021
- UPLD 2014
- Fundamental
- Price
- CNTX $1.13
- UPLD $2.37
- Analyst Decision
- CNTX Strong Buy
- UPLD Strong Buy
- Analyst Count
- CNTX 7
- UPLD 1
- Target Price
- CNTX $5.20
- UPLD $4.50
- AVG Volume (30 Days)
- CNTX 260.4K
- UPLD 144.9K
- Earning Date
- CNTX 11-05-2025
- UPLD 11-06-2025
- Dividend Yield
- CNTX N/A
- UPLD N/A
- EPS Growth
- CNTX N/A
- UPLD N/A
- EPS
- CNTX N/A
- UPLD N/A
- Revenue
- CNTX N/A
- UPLD $251,757,000.00
- Revenue This Year
- CNTX N/A
- UPLD N/A
- Revenue Next Year
- CNTX N/A
- UPLD N/A
- P/E Ratio
- CNTX N/A
- UPLD N/A
- Revenue Growth
- CNTX N/A
- UPLD N/A
- 52 Week Low
- CNTX $0.49
- UPLD $1.69
- 52 Week High
- CNTX $2.59
- UPLD $5.64
- Technical
- Relative Strength Index (RSI)
- CNTX 69.12
- UPLD 47.20
- Support Level
- CNTX $0.98
- UPLD $2.29
- Resistance Level
- CNTX $1.29
- UPLD $2.57
- Average True Range (ATR)
- CNTX 0.09
- UPLD 0.14
- MACD
- CNTX 0.02
- UPLD -0.02
- Stochastic Oscillator
- CNTX 65.91
- UPLD 33.31
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About UPLD Upland Software Inc.
Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels.